These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 17660250
21. Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display. Hosseini A, Kumar S, Hedin K, Raeeszadeh-Sarmazdeh M. Protein Sci; 2023 Dec; 32(12):e4795. PubMed ID: 37807423 [Abstract] [Full Text] [Related]
22. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Morgunova E, Tuuttila A, Bergmann U, Tryggvason K. Proc Natl Acad Sci U S A; 2002 May 28; 99(11):7414-9. PubMed ID: 12032297 [Abstract] [Full Text] [Related]
24. Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2). Higashi S, Hirose T, Takeuchi T, Miyazaki K. J Biol Chem; 2013 Mar 29; 288(13):9066-76. PubMed ID: 23395821 [Abstract] [Full Text] [Related]
25. Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14. Zou H, Wu Y, Brew K. J Biol Chem; 2016 May 20; 291(21):11348-58. PubMed ID: 27033700 [Abstract] [Full Text] [Related]
26. Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria. Van Doren SR, Wei S, Gao G, DaGue BB, Palmier MO, Bahudhanapati H, Brew K. Biopolymers; 2008 Nov 20; 89(11):960-8. PubMed ID: 18615493 [Abstract] [Full Text] [Related]
28. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M, Soloway PD, DeClerck YA, Fridman R. J Biol Chem; 2004 Mar 05; 279(10):8592-601. PubMed ID: 14681236 [Abstract] [Full Text] [Related]
30. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy. Sekiuchi M, Kudo A, Nakabayashi K, Kanai-Azuma M, Akimoto Y, Kawakami H, Yamada A. Clin Exp Nephrol; 2012 Dec 05; 16(6):863-74. PubMed ID: 22614167 [Abstract] [Full Text] [Related]
32. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints. Takei I, Takagi M, Santavirta S, Ida H, Hamasaki M, Ishii M, Fukushima S, Ogino T, Konttinen YT. J Biomed Mater Res; 1999 Jun 05; 45(3):175-83. PubMed ID: 10397973 [Abstract] [Full Text] [Related]
33. High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3. Muskett FW, Frenkiel TA, Feeney J, Freedman RB, Carr MD, Williamson RA. J Biol Chem; 1998 Aug 21; 273(34):21736-43. PubMed ID: 9705310 [Abstract] [Full Text] [Related]
34. Entropy increases from different sources support the high-affinity binding of the N-terminal inhibitory domains of tissue inhibitors of metalloproteinases to the catalytic domains of matrix metalloproteinases-1 and -3. Wu Y, Wei S, Van Doren SR, Brew K. J Biol Chem; 2011 May 13; 286(19):16891-9. PubMed ID: 21454617 [Abstract] [Full Text] [Related]
35. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Pérez P, Kwon YJ, Alliende C, Leyton L, Aguilera S, Molina C, Labra C, Julio M, Leyton C, González MJ. Arthritis Rheum; 2005 Sep 13; 52(9):2751-60. PubMed ID: 16142742 [Abstract] [Full Text] [Related]
36. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors. Nagase H, Brew K. Biochem Soc Symp; 2003 Sep 13; (70):201-12. PubMed ID: 14587293 [Abstract] [Full Text] [Related]
37. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V. Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911 [Abstract] [Full Text] [Related]
38. Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)). Bahudhanapati H, Zhang Y, Sidhu SS, Brew K. J Biol Chem; 2011 Sep 09; 286(36):31761-70. PubMed ID: 21715326 [Abstract] [Full Text] [Related]
39. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows. Grzesiak M, Kaminska K, Knapczyk-Stwora K, Hrabia A. Theriogenology; 2022 Jun 09; 185():109-120. PubMed ID: 35395587 [Abstract] [Full Text] [Related]
40. Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain. Kai HS, Butler GS, Morrison CJ, King AE, Pelman GR, Overall CM. J Biol Chem; 2002 Dec 13; 277(50):48696-707. PubMed ID: 12374789 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]